EU Dry Eye Disease Market Business Scenario Analysis By Global Industry Trend, and Opportunity Assessment till 2028

The EU Dry Eye Disease Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global EU Dry Eye Disease market. This report explores all the key factors affecting the growth of the global EU Dry Eye Disease market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141760/

Report Description of the EU Dry Eye Disease Market Analysis

Research Scope and Assumption

The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
Inflation has not been accounted for in order to estimate and forecast the market
Numbers may not add up due to rounding off

Reason to buy the report:

Facilitate decision-making based on strong current and forecast data for EU Dry Eye Disease Market Analysis
Develop strategies based on the latest regulatory framework
Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the EU Dry Eye Disease Market Analysis
Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
To strategically profile key players and comprehensively analyze their market shares and core competencies
We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

EU Dry Eye Disease Market Analysis Executive Summary

Dry eye is a type of ocular surface disease that causes the eye not to produce enough tears and is linked with symptoms of ocular discomfort. Dry eye disease is also called keratitis sicca, keratoconjunctivitis sicca (KCS), xerophthalmia, dry eye syndrome (DES) and dysfunctional tear syndrome (DTS). Research and development activities and clinical trials are expected to gain traction to boost the penetration of dry eyes treatments and medications.

Market Size and Key Findings

The EU Dry Eye Disease Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 5.42% during the forecast period.

The Europe dry eye disease market is anticipated to record a CAGR of 5.42% during the projected period of 2021 to 2028. Factors such as the growing awareness regarding dry eye disease, the increasing prevalence of glaucoma, the rising geriatric population, and the surging market consolidation are predominately credited to the regions market growth.

Market Dynamics

Market Growth Drivers Analysis

Several factors, such as aging, decrease in the supportive hormones, systemic inflammatory diseases, ocular surface diseases, or surgeries that affect the cholinergic nerves, which stimulate tear secretion, may be associated with the rise in dry eye-related diseases.

A significant percentage of the global population (middle age to older age) suffers from the dry eye disease. As number of elderly population is projected to increase, and this population are more prone to eye-related disorders, such as dry eye, which ultimately drives the market in the near future.

Market Restraints

However, high cost of specialty dry eye products with complex reimbursement scenario and availability of alternative therapies is likely to limit the market growth over the forecast period.

COVID-19 impact on EU Dry Eye Disease Market

The outbreak of the COVID-19 pandemic in 2020 resulted in the disruption of healthcare systems by posing several challenges, including to the practice of ophthalmology. However, urgent and essential treatments were being allowed in most countries.

Competitive Landscape

Key Players

The major players covered in the dry eye syndrome market report are Allergan, Bausch & Lomb Incorporated, Novartis Ag, Johnson & Johnson Private Limited., Prestige Consumer Healthcare, Inc., Akorn Operating Company LLC., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Novaliq Gmbh, Santen Pharmaceutical Co., Ltd., Cardinal Health, Alembic Pharmaceuticals Limited., Cipla Inc., Perrigo Company Plc, Senju Pharmaceutical Co. Ltd., Horus Pharma, Rohto Pharmaceutical Co., Ltd., Visufarma, Hubrx Ltd, among others.

Products in Pipeline

In 2020, the FDA had approved loteprednol etabonate ophthalmic suspension 0.25% for the short-term treatment of the signs and symptoms of dry eye disease.
Many drugs are in the pipeline for the disease, which is boosting the market growth in the region. For instance, RegeneRxs RGN-259, a T4-based sterile and preservative-free eye drop, is designed to be a novel treatment for dry eye and neurotrophic keratitis. This is in the Phase II/III study for dry eye syndrome that includes 317 patients.

Notable Recent Deals

Abbvie expanded the REFRESH Portfolio by introducing the over-the-counter (OTC) artificial tear formulation, REFRESH Repair Lubricant Eye Drops, to treat dry eye disease, in 2018. All these novel product launches may give the country a cutting edge in the market growth.

Two of the major companies established in this segment are Bausch Health and AbbVie Inc. (Allergan PLC). Often, these companies, as well as doctors, recommend corticosteroids, along with antibiotic therapy.

In July 2019, Novartis announced the acquisition of Xiidra. Xiidra is the first and only prescription treatment approved by the U.S. FDA for both signs and symptoms of dry eye disease, with a mechanism of action that targets inflammation.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

Governments and institutions are likely to take advantage of their advanced technologies during this period to turn the challenges brought by COVID-19 into opportunities. Ophthalmic consultation largely through smartphones has become a lifeline for consultation. For follow up on eye disorders, doctors are using images via electronic media. For poor patients in remote rural areas with no phone, this follow up was not possible. In remote areas, rural medicine supply for dry eye disorder patients has dried up.

To Know More About COVID-19 Impact On EU Dry Eye Disease Market @ https://www.prudentmarkets.com/sample-request/141760/

EU Dry Eye Disease Market Analysis Segmentation

By Type:

Based on type the Europe Dry Eye Product is segmented into OTC drugs and prescription drugs. Among which OTC drugs held largest market share in 2019 and is expected to show dominance during forecast period. And Prescription drugs expected to show highest CAGR rate during forecast period.

By Product:

Based on product the Europe Dry Eye Product Market is segmented into Artificial tears, Antibiotic drops, Hormone drops and others. Among which Artificial tears segment held the strongest share in year 2019 and is expected to show its dominance during forecast period. Hormone drops is expected to show highest CAGR during forecast period.

By Distribution Channel:

Retail pharmacies are the largest segment by distribution channel of the Dry eye syndrome market. The vast network of retail pharmacies makes them close to patient customers. Moreover, easy access and buying procedures are growth-promoting factors. However, the online pharmacies segment is witnessing a higher growth rate owing to the increasing penetration of the internet.

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141760/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global EU Dry Eye Disease Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global EU Dry Eye Disease Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the EU Dry Eye Disease market
Chapter 2: Exclusive Summary - the basic information of the EU Dry Eye Disease Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the EU Dry Eye Disease
Chapter 4: Presenting the EU Dry Eye Disease Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the EU Dry Eye Disease market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141760/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the EU Dry Eye Disease Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.